rs114171764

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_001166108.2(PALLD):​c.2723G>A​(p.Arg908His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000781 in 1,612,730 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R908C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000073 ( 0 hom. )

Consequence

PALLD
NM_001166108.2 missense

Scores

4
8
4

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 10.0

Publications

4 publications found
Variant links:
Genes affected
PALLD (HGNC:17068): (palladin, cytoskeletal associated protein) This gene encodes a cytoskeletal protein that is required for organizing the actin cytoskeleton. The protein is a component of actin-containing microfilaments, and it is involved in the control of cell shape, adhesion, and contraction. Polymorphisms in this gene are associated with a susceptibility to pancreatic cancer type 1, and also with a risk for myocardial infarction. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]
CBR4 (HGNC:25891): (carbonyl reductase 4) Enables several functions, including 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity; NADPH binding activity; and NADPH dehydrogenase (quinone) activity. Involved in fatty acid biosynthetic process; glycoside metabolic process; and protein tetramerization. Located in mitochondrial matrix. Part of oxidoreductase complex. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.019320339).
BP6
Variant 4-168915900-G-A is Benign according to our data. Variant chr4-168915900-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 238607.
BS2
High AC in GnomAd4 at 20 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001166108.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PALLD
NM_001166108.2
MANE Select
c.2723G>Ap.Arg908His
missense
Exon 17 of 22NP_001159580.1Q8WX93-9
PALLD
NM_016081.4
c.2672G>Ap.Arg891His
missense
Exon 16 of 21NP_057165.3
PALLD
NM_001166109.2
c.1526G>Ap.Arg509His
missense
Exon 15 of 19NP_001159581.1Q8WX93-8

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PALLD
ENST00000505667.6
TSL:1 MANE Select
c.2723G>Ap.Arg908His
missense
Exon 17 of 22ENSP00000425556.1Q8WX93-9
PALLD
ENST00000261509.10
TSL:1
c.2672G>Ap.Arg891His
missense
Exon 16 of 21ENSP00000261509.6Q8WX93-2
PALLD
ENST00000507735.6
TSL:1
c.1211G>Ap.Arg404His
missense
Exon 8 of 12ENSP00000424016.1Q8WX93-4

Frequencies

GnomAD3 genomes
AF:
0.000132
AC:
20
AN:
152082
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000725
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00308
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000247
AC:
62
AN:
251222
AF XY:
0.000243
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000289
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.0000726
AC:
106
AN:
1460530
Hom.:
0
Cov.:
29
AF XY:
0.0000702
AC XY:
51
AN XY:
726692
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33450
American (AMR)
AF:
0.0000447
AC:
2
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26130
East Asian (EAS)
AF:
0.00192
AC:
76
AN:
39676
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86228
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53398
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
0.0000189
AC:
21
AN:
1110808
Other (OTH)
AF:
0.0000663
AC:
4
AN:
60354
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
5
11
16
22
27
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000131
AC:
20
AN:
152200
Hom.:
0
Cov.:
32
AF XY:
0.000161
AC XY:
12
AN XY:
74388
show subpopulations
African (AFR)
AF:
0.0000723
AC:
3
AN:
41518
American (AMR)
AF:
0.00
AC:
0
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00309
AC:
16
AN:
5180
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10584
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68024
Other (OTH)
AF:
0.000473
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.515
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000104
Hom.:
0
Bravo
AF:
0.000132
ExAC
AF:
0.000206
AC:
25
EpiCase
AF:
0.000109
EpiControl
AF:
0.00

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
not specified (1)
-
-
1
Pancreatic adenocarcinoma (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.33
BayesDel_addAF
Benign
-0.12
T
BayesDel_noAF
Uncertain
0.060
CADD
Pathogenic
33
DANN
Pathogenic
1.0
Eigen
Pathogenic
0.82
Eigen_PC
Pathogenic
0.82
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.90
D
M_CAP
Benign
0.025
D
MetaRNN
Benign
0.019
T
MetaSVM
Uncertain
-0.13
T
PhyloP100
10
PrimateAI
Uncertain
0.69
T
PROVEAN
Uncertain
-3.2
D
REVEL
Uncertain
0.42
Sift
Uncertain
0.0060
D
Sift4G
Uncertain
0.0050
D
Vest4
0.47
MVP
0.77
MPC
0.86
ClinPred
0.17
T
GERP RS
5.7
gMVP
0.48
Mutation Taster
=43/57
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.080
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs114171764; hg19: chr4-169837051; COSMIC: COSV99823682; COSMIC: COSV99823682; API